mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.01 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.02 |